As of April 15, 2025, Vaxcyte (PCVX) has a market cap of $3.89 billion USD. According to our data, Vaxcyte is ranked No.2950 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $3.89 B |
-61.85%
|
Dec 31, 2024 | $10.20 B |
30.35%
|
Dec 29, 2023 | $7.83 B |
30.97%
|
Dec 30, 2022 | $5.98 B |
101.56%
|
Dec 31, 2021 | $2.97 B |
-10.46%
|
Dec 31, 2020 | $3.31 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
Market Cap | = | PCVX Stock Price | * | PCVX Shares Outstanding |
= | $30.23 | * | 0.13 B | |
= | $3.89 B |